Prof. Dr. med. Michael Albert

Facharzt für Kinder- und Jugendmedizin, Kinder-Hämatologie und -Onkologie

---

Vita

Wichtige Publikationen

• Albert, M.H., et al., X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. 2010. 115(16): p. 3231-8.

• Albert, M.H., L.D. Notarangelo, and H.D. Ochs, Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol, 2011. 18(1): p. 42-8.

• Aydin, S.E., et al., DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol, 2015. 35(2): p. 189-98.

• Hauck, F., et al., Diagnostic and Treatment Options for Severe IBD in Female X-CGD Carriers with Non-random X-inactivation. J Crohns Colitis, 2016. 10(1): p. 112-5.

• Albert, M.H., et al. Allogeneic stem cell transplantation in adolescents and young adults with primary immunodeficiencies. Allergy Clin Immunol Pract, 2018. 6(1): p. 298-301.e2

• Magg, T., et al., IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective T(Reg) cell engraftment. Clin Immunol, 2018. 191: p. 52-58

• Albert, M.H. and A.F. Freeman, Wiskott-Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8- (DOCK8) Deficiency. Front Pediatr, 2019. 7: p. 451

• Aydin, S.E., et al., Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency. J Allergy Clin Immunol Pract, 2019. 7(3): p. 848-855

• Morris, E.C. and M.H. Albert, Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies. Front Pediatr, 2019. 7: p. 437

• Chiesa, R., et al., Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood, 2020. 136(10): p. 1201-1211